Key Market Indicators
Peru's vaccination coverage for children aged one year is projected to remain steady at 86% by 2028, showing no change from 2023 levels. This stagnation follows a historical trend, with the market growing at an average rate of 0.7 percentage points annually since 1985. In contrast, Peru's vaccine import sector is set for significant growth. By 2028, vaccine imports are expected to reach approximately $128 million, up from $112 million in 2023. This represents an average annual growth rate of 2% since 1997, when the demand increased by 3.1% year on year. However, the outlook for Peruvian vaccine exports is less optimistic. By 2028, exports are projected to decrease to around $83,000 from $94,000 in 2023, marking an average annual decline of 2.2%. Despite this downturn, Peru's supply has seen a remarkable 61% year-on-year increase since 2002. In 2023, Peru ranked 49th in the world for vaccine exports, with Mauritius just ahead. Belgium, the United Kingdom, and France held the second, third, and fourth spots, respectively.
